187 related articles for article (PubMed ID: 17002300)
1. Kinetic properties of a MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways.
Adayev T; Chen-Hwang MC; Murakami N; Wegiel J; Hwang YW
Biochemistry; 2006 Oct; 45(39):12011-9. PubMed ID: 17002300
[TBL] [Abstract][Full Text] [Related]
2. Mnb/Dyrk1A phosphorylation regulates the interaction of dynamin 1 with SH3 domain-containing proteins.
Huang Y; Chen-Hwang MC; Dolios G; Murakami N; Padovan JC; Wang R; Hwang YW
Biochemistry; 2004 Aug; 43(31):10173-85. PubMed ID: 15287745
[TBL] [Abstract][Full Text] [Related]
3. Cell type- and brain structure-specific patterns of distribution of minibrain kinase in human brain.
Wegiel J; Kuchna I; Nowicki K; Frackowiak J; Dowjat K; Silverman WP; Reisberg B; DeLeon M; Wisniewski T; Adayev T; Chen-Hwang MC; Hwang YW
Brain Res; 2004 Jun; 1010(1-2):69-80. PubMed ID: 15126119
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of amphiphysin I by minibrain kinase/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome.
Murakami N; Xie W; Lu RC; Chen-Hwang MC; Wieraszko A; Hwang YW
J Biol Chem; 2006 Aug; 281(33):23712-24. PubMed ID: 16733250
[TBL] [Abstract][Full Text] [Related]
5. Dual-specificity tyrosine-phosphorylated and regulated kinase 1A (DYRK1A) interacts with the phytanoyl-CoA alpha-hydroxylase associated protein 1 (PAHX-AP1), a brain specific protein.
Bescond M; Rahmani Z
Int J Biochem Cell Biol; 2005 Apr; 37(4):775-83. PubMed ID: 15694837
[TBL] [Abstract][Full Text] [Related]
6. The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development.
Hämmerle B; Elizalde C; Tejedor FJ
Eur J Neurosci; 2008 Mar; 27(5):1061-74. PubMed ID: 18364031
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the human MNB/DYRK1A gene induces formation of multinucleate cells through overduplication of the centrosome.
Funakoshi E; Hori T; Haraguchi T; Hiraoka Y; Kudoh J; Shimizu N; Ito F
BMC Cell Biol; 2003 Sep; 4():12. PubMed ID: 12964950
[TBL] [Abstract][Full Text] [Related]
8. MNB/DYRK1A as a multiple regulator of neuronal development.
Tejedor FJ; Hämmerle B
FEBS J; 2011 Jan; 278(2):223-35. PubMed ID: 21156027
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans.
De la Torre R; De Sola S; Pons M; Duchon A; de Lagran MM; Farré M; Fitó M; Benejam B; Langohr K; Rodriguez J; Pujadas M; Bizot JC; Cuenca A; Janel N; Catuara S; Covas MI; Blehaut H; Herault Y; Delabar JM; Dierssen M
Mol Nutr Food Res; 2014 Feb; 58(2):278-88. PubMed ID: 24039182
[TBL] [Abstract][Full Text] [Related]
10. Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity in vitro.
Adayev T; Chen-Hwang MC; Murakami N; Lee E; Bolton DC; Hwang YW
Biochemistry; 2007 Jun; 46(25):7614-24. PubMed ID: 17536841
[TBL] [Abstract][Full Text] [Related]
11. High-level expression of the Mnb/Dyrk1A gene in brain and heart during rat early development.
Okui M; Ide T; Morita K; Funakoshi E; Ito F; Ogita K; Yoneda Y; Kudoh J; Shimizu N
Genomics; 1999 Dec; 62(2):165-71. PubMed ID: 10610708
[TBL] [Abstract][Full Text] [Related]
12. [Minibrain/DYRK1A gene: candidate gene for mental retardation in Down's syndrome?].
Kentrup H; Joost HG; Heimann G; Becker W
Klin Padiatr; 2000; 212(2):60-3. PubMed ID: 10812554
[TBL] [Abstract][Full Text] [Related]
13. Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup
Gu Y; Moroy G; Paul JL; Rebillat AS; Dierssen M; de la Torre R; Cieuta-Walti C; Dairou J; Janel N
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092951
[TBL] [Abstract][Full Text] [Related]
14. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ
J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of peanut serine/threonine/tyrosine protein kinase: molecular docking and inhibition kinetics with tyrosine kinase inhibitors.
Rudrabhatla P; Rajasekharan R
Biochemistry; 2004 Sep; 43(38):12123-32. PubMed ID: 15379551
[TBL] [Abstract][Full Text] [Related]
16. Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation.
Göckler N; Jofre G; Papadopoulos C; Soppa U; Tejedor FJ; Becker W
FEBS J; 2009 Nov; 276(21):6324-37. PubMed ID: 19796173
[TBL] [Abstract][Full Text] [Related]
17. Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A).
Adayev T; Wegiel J; Hwang YW
Arch Biochem Biophys; 2011 Mar; 507(2):212-8. PubMed ID: 21185805
[TBL] [Abstract][Full Text] [Related]
18. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.
Kimura R; Kamino K; Yamamoto M; Nuripa A; Kida T; Kazui H; Hashimoto R; Tanaka T; Kudo T; Yamagata H; Tabara Y; Miki T; Akatsu H; Kosaka K; Funakoshi E; Nishitomi K; Sakaguchi G; Kato A; Hattori H; Uema T; Takeda M
Hum Mol Genet; 2007 Jan; 16(1):15-23. PubMed ID: 17135279
[TBL] [Abstract][Full Text] [Related]
19. Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome.
McElyea SD; Starbuck JM; Tumbleson-Brink DM; Harrington E; Blazek JD; Ghoneima A; Kula K; Roper RJ
Hum Mol Genet; 2016 Nov; 25(22):4856-4869. PubMed ID: 28172997
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Dyrk1A kinase activity by 14-3-3.
Kim D; Won J; Shin DW; Kang J; Kim YJ; Choi SY; Hwang MK; Jeong BW; Kim GS; Joe CO; Chung SH; Song WJ
Biochem Biophys Res Commun; 2004 Oct; 323(2):499-504. PubMed ID: 15369779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
